Amgen Inc Stock Performance
| AMGN Stock | USD 292.09 0.93 0.32% |
The firm shows a Beta (market volatility) of 0.79, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amgen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amgen is expected to be smaller as well. At this point, Amgen Inc has a negative expected return of -0.0243%. Please make sure to confirm Amgen's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Amgen Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Amgen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.21) | Five Day Return (3.36) | Year To Date Return 12.3 | Ten Year Return 79.75 | All Time Return 84.6 K |
Forward Dividend Yield 0.0326 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 9.52 | Dividend Date 2025-09-12 |
| Amgen dividend paid on 12th of September 2025 | 09/12/2025 |
1 | Amgen Laps the Stock Market Heres Why | 10/15/2025 |
2 | Empirical Asset Management LLC Purchases 3,172 Shares of Amgen Inc. AMGN | 10/17/2025 |
3 | Schnieders Capital Management LLC Has 7.22 Million Holdings in Amgen Inc. AMGN | 10/20/2025 |
4 | Breakthrough Women in Science Medicine episode addresses the obesity epidemic Premiering on PBS, November 1st | 10/21/2025 |
5 | Avidian Wealth Enterprises LLC Increases Stake in Amgen Inc. AMGN | 10/22/2025 |
6 | Onyx Bridge Wealth Group LLC Buys 108 Shares of Amgen Inc. AMGN | 10/23/2025 |
| Begin Period Cash Flow | 10.9 B | |
| Total Cashflows From Investing Activities | -1 B |
Amgen Relative Risk vs. Return Landscape
If you would invest 29,894 in Amgen Inc on July 30, 2025 and sell it today you would lose (685.00) from holding Amgen Inc or give up 2.29% of portfolio value over 90 days. Amgen Inc is currently does not generate positive expected returns and assumes 1.5589% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of stocks are less volatile than Amgen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Amgen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amgen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amgen Inc, and traders can use it to determine the average amount a Amgen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0156
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AMGN |
Estimated Market Risk
| 1.56 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Amgen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amgen by adding Amgen to a well-diversified portfolio.
Amgen Fundamentals Growth
Amgen Stock prices reflect investors' perceptions of the future prospects and financial health of Amgen, and Amgen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amgen Stock performance.
| Return On Equity | 0.99 | ||||
| Return On Asset | 0.0751 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 208.28 B | ||||
| Shares Outstanding | 538.36 M | ||||
| Price To Earning | 22.74 X | ||||
| Price To Book | 21.55 X | ||||
| Price To Sales | 4.50 X | ||||
| Revenue | 33.42 B | ||||
| Gross Profit | 24.22 B | ||||
| EBITDA | 13.36 B | ||||
| Net Income | 4.09 B | ||||
| Cash And Equivalents | 11.48 B | ||||
| Cash Per Share | 21.51 X | ||||
| Total Debt | 60.1 B | ||||
| Current Ratio | 1.68 X | ||||
| Book Value Per Share | 13.80 X | ||||
| Cash Flow From Operations | 11.49 B | ||||
| Earnings Per Share | 12.22 X | ||||
| Market Capitalization | 157.07 B | ||||
| Total Asset | 91.84 B | ||||
| Retained Earnings | (27.59 B) | ||||
| Working Capital | 5.93 B | ||||
| Current Asset | 38.52 B | ||||
| Current Liabilities | 8.67 B | ||||
About Amgen Performance
By examining Amgen's fundamental ratios, stakeholders can obtain critical insights into Amgen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Amgen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 198.65 | 215.53 | |
| Return On Tangible Assets | 0.09 | 0.12 | |
| Return On Capital Employed | 0.11 | 0.21 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.70 | 0.73 |
Things to note about Amgen Inc performance evaluation
Checking the ongoing alerts about Amgen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amgen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amgen Inc generated a negative expected return over the last 90 days | |
| Over 84.0% of the company shares are held by institutions such as insurance companies | |
| On 12th of September 2025 Amgen paid $ 2.38 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Onyx Bridge Wealth Group LLC Buys 108 Shares of Amgen Inc. AMGN |
- Analyzing Amgen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amgen's stock is overvalued or undervalued compared to its peers.
- Examining Amgen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amgen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amgen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amgen's stock. These opinions can provide insight into Amgen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.92 | Dividend Share 9.26 | Earnings Share 12.22 | Revenue Per Share | Quarterly Revenue Growth 0.094 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.